Details for New Drug Application (NDA): 019798
✉ Email this page to a colleague
The generic ingredient in NASACORT is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 019798
Tradename: | NASACORT |
Applicant: | Chattem Sanofi |
Ingredient: | triamcinolone acetonide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 019798
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;NASAL | Strength | 0.055MG/INH | ||||
Approval Date: | Jul 11, 1991 | TE: | RLD: | No |
Expired US Patents for NDA 019798
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | NASACORT | triamcinolone acetonide | AEROSOL, METERED;NASAL | 019798-001 | Jul 11, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription